 | • レポートコード：MRC2103G037 • 出版社/出版日：Transparency Market Research / 2021年1月25日 • レポート形態：英文、PDF、194ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Site Licence | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Enterprisewide Licence | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、世界のハイパーサーミア癌治療市場を広く調査・分析し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、市場動向、装置タイプ別（赤外線装置、超音波装置、マイクロ波装置、その他）分析、治療法別分析、用途別分析、エンドユーザー別分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況など、以下の構成でまとめております。 ・序論 ・仮定・調査手法 ・エグゼクティブサマリー ・市場概要 ・市場動向 ・ハイパーサーミア癌治療の世界市場規模：装置タイプ別（赤外線装置、超音波装置、マイクロ波装置、その他） ・ハイパーサーミア癌治療の世界市場規模：治療法別 ・ハイパーサーミア癌治療の世界市場規模：用途別 ・ハイパーサーミア癌治療の世界市場規模：エンドユーザー別別 ・ハイパーサーミア癌治療の世界市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ） ・競争状況 |
Hyperthermia Cancer Treatment Market – Scope of the Report
TMR’s report on the global hyperthermia cancer treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators for the market during the forecast period from 2020 to 2030. The report provides revenue of the global hyperthermia cancer treatment market for the period 2018–2030, considering 2019 as the base year and 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global hyperthermia cancer treatment market from 2020 to 2030.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the hyperthermia cancer treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global hyperthermia cancer treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global hyperthermia cancer treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global hyperthermia cancer treatment market.
The report delves into the competition landscape of the global hyperthermia cancer treatment market. Key players operating in the global hyperthermia cancer treatment market are identified and each one of these is profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global hyperthermia cancer treatment market profiled in this report.
Key Questions Answered in Hyperthermia Cancer Treatment Market Report
What is the sales/revenue generated by hyperthermia cancer treatment across all regions during the forecast period?
What are the opportunities in the global hyperthermia cancer treatment market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which device type segment is expected to generate the highest revenue globally in 2030? Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Hyperthermia Cancer Treatment Market – Research Objectives and Research Approach
The comprehensive report on the global hyperthermia cancer treatment market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller sections. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global hyperthermia cancer treatment market in terms of device type, treatment method, application, end user, and region. Key segments under each criteria are studied at length, and the market share for each of these at the end of 2030 has also been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global hyperthermia cancer treatment market.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunity
4.3. Global Hyperthermia Cancer Treatment Market Forecast
4.4. Global Hyperthermia Cancer Treatment Market Outlook
5. Market Outlook
5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
5.2. Epidemiology of Cancer Globally/Country
5.3. Reimbursement Scenario
5.4. Regulatory Scenario
5.5. Overview on Combination Cancer Treatment Strategies along with Hyperthermia
6. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type
6.1. Introduction
6.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
6.3. Global Hyperthermia Cancer Treatment Market Forecast, by Device Type
6.3.1. Infrared Hyperthermia Devices
6.3.2. Ultrasound Hyperthermia Devices
6.3.3. Microwave Hyperthermia Devices
6.3.4. Others
6.4. Global Hyperthermia Cancer Treatment Market Analysis, by Device Type
7. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method
7.1. Introduction
7.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
7.3. Global Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
7.3.1. Locoregional
7.3.1.1. External & Interstitial
7.3.1.2. Intraluminal or Endocavitary Methods
7.3.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
7.3.1.4. Deep Tissue & Regional Perfusion
7.3.2. Whole-body
7.4. Global Hyperthermia Cancer Treatment Market Analysis, by Treatment Method
8. Global Hyperthermia Cancer Treatment Market Analysis, by Application
8.1. Introduction
8.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
8.3. Global Hyperthermia Cancer Treatment Market Forecast, by Application
8.3.1. Breast Cancer
8.3.2. Liver Cancer
8.3.3. Soft Tissue Sarcoma
8.3.4. Head & Neck Tumors
8.3.5. Prostate Cancer
8.3.6. Others
8.4. Global Hyperthermia Cancer Treatment Market Analysis, by Application
9. Global Hyperthermia Cancer Treatment Market Analysis, by End-user
9.1. Introduction
9.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
9.3. Global Hyperthermia Cancer Treatment Market Forecast, by End-user
9.3.1. Hospitals & Specialty Clinics
9.3.2. Ambulatory Surgical Centers
9.3.3. Others
9.4. Global Hyperthermia Cancer Treatment Market Analysis, by End-user
10. Global Hyperthermia Cancer Treatment Market Analysis, by Region
10.1. Global Hyperthermia Cancer Treatment Market Scenario, by Region/Country
10.2. Global Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Region
10.3. Global Hyperthermia Cancer Treatment Market Forecast, by Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
11. North America Hyperthermia Cancer Treatment Market Analysis
11.1. North America Hyperthermia Cancer Treatment Market Overview
11.2. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country
11.3. North America Hyperthermia Cancer Treatment Market Forecast, by Country
11.3.1. U.S.
11.3.2. Canada
11.4. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
11.5. North America Hyperthermia Cancer Treatment Market Forecast, by Device Type
11.5.1. Infrared Hyperthermia Devices
11.5.2. Ultrasound Hyperthermia Devices
11.5.3. Microwave Hyperthermia Devices
11.5.4. Others
11.6. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
11.7. North America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
11.7.1. Locoregional
11.7.1.1. External & Interstitial
11.7.1.2. Intraluminal or Endocavitary Methods
11.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
11.7.1.4. Deep Tissue & Regional Perfusion
11.7.2. Whole-body
11.8. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
11.9. North America Hyperthermia Cancer Treatment Market Forecast, by Application
11.9.1. Breast Cancer
11.9.2. Liver Cancer
11.9.3. Soft Tissue Sarcoma
11.9.4. Head & Neck Tumors
11.9.5. Prostate Cancer
11.9.6. Others
11.10. North America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
11.11. North America Hyperthermia Cancer Treatment Market Forecast, by End-user
11.11.1. Hospitals & Specialty Clinics
11.11.2. Ambulatory Surgical Centers
11.11.3. Others
12. Europe Hyperthermia Cancer Treatment Market Analysis
12.1. Europe Hyperthermia Cancer Treatment Market Overview
12.2. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
12.3. Europe Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Rest of Europe
12.4. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
12.5. Europe Hyperthermia Cancer Treatment Market Forecast, by Device Type
12.5.1. Infrared Hyperthermia Devices
12.5.2. Ultrasound Hyperthermia Devices
12.5.3. Microwave Hyperthermia Devices
12.5.4. Others
12.6. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
12.7. Europe Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
12.7.1. Locoregional
12.7.1.1. External & Interstitial
12.7.1.2. Intraluminal or Endocavitary Methods
12.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
12.7.1.4. Deep Tissue & Regional Perfusion
12.7.2. Whole-body
12.8. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
12.9. Europe Hyperthermia Cancer Treatment Market Forecast, by Application
12.9.1. Breast Cancer
12.9.2. Liver Cancer
12.9.3. Soft Tissue Sarcoma
12.9.4. Head & Neck Tumors
12.9.5. Prostate Cancer
12.9.6. Others
12.10. Europe Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
12.11. Europe Hyperthermia Cancer Treatment Market Forecast, by End-user
12.11.1. Hospitals & Specialty Clinics
12.11.2. Ambulatory Surgical Centers
12.11.3. Others
13. Asia Pacific Hyperthermia Cancer Treatment Market Analysis
13.1. Asia Pacific Hyperthermia Cancer Treatment Market Overview
13.2. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
13.3.1. Japan
13.3.2. China
13.3.3. India
13.3.4. Australia & New Zealand
13.3.5. Rest of Asia Pacific
13.4. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
13.5. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Device Type
13.5.1. Infrared Hyperthermia Devices
13.5.2. Ultrasound Hyperthermia Devices
13.5.3. Microwave Hyperthermia Devices
13.5.4. Others
13.6. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
13.7. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
13.7.1. Locoregional
13.7.1.1. External & Interstitial
13.7.1.2. Intraluminal or Endocavitary Methods
13.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
13.7.1.4. Deep Tissue & Regional Perfusion
13.7.2. Whole-body
13.8. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
13.9. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by Application
13.9.1. Breast Cancer
13.9.2. Liver Cancer
13.9.3. Soft Tissue Sarcoma
13.9.4. Head & Neck Tumors
13.9.5. Prostate Cancer
13.9.6. Others
13.10. Asia Pacific Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
13.11. Asia Pacific Hyperthermia Cancer Treatment Market Forecast, by End-user
13.11.1. Hospitals & Specialty Clinics
13.11.2. Ambulatory Surgical Centers
13.11.3. Others
14. Latin America Hyperthermia Cancer Treatment Market Analysis
14.1. Latin America Hyperthermia Cancer Treatment Market Overview
14.2. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Latin America Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
14.3.1. Brazil
14.3.2. Mexico
14.3.3. Rest of Latin America
14.4. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
14.5. Latin America Hyperthermia Cancer Treatment Market Forecast, by Device Type
14.5.1. Infrared Hyperthermia Devices
14.5.2. Ultrasound Hyperthermia Devices
14.5.3. Microwave Hyperthermia Devices
14.5.4. Others
14.6. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
14.7. Latin America Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
14.7.1. Locoregional
14.7.1.1. External & Interstitial
14.7.1.2. Intraluminal or Endocavitary Methods
14.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
14.7.1.4. Deep Tissue & Regional Perfusion
14.7.2. Whole-body
14.8. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
14.9. Latin America Hyperthermia Cancer Treatment Market Forecast, by Application
14.9.1. Breast Cancer
14.9.2. Liver Cancer
14.9.3. Soft Tissue Sarcoma
14.9.4. Head & Neck Tumors
14.9.5. Prostate Cancer
14.9.6. Others
14.10. Latin America Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
14.11. Latin America Hyperthermia Cancer Treatment Market Forecast, by End-user
14.11.1. Hospitals & Specialty Clinics
14.11.2. Ambulatory Surgical Centers
14.11.3. Others
15. Middle East & Africa Hyperthermia Cancer Treatment Market Analysis
15.1. Middle East & Africa Hyperthermia Cancer Treatment Market Overview
15.2. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Country/Sub-region
15.3.1. GCC Countries
15.3.2. South Africa
15.3.3. Rest of Middle East & Africa
15.4. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Device Type
15.5. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Device Type
15.5.1. Infrared Hyperthermia Devices
15.5.2. Ultrasound Hyperthermia Devices
15.5.3. Microwave Hyperthermia Devices
15.5.4. Others
15.6. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Treatment Method
15.7. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Treatment Method
15.7.1. Locoregional
15.7.1.1. External & Interstitial
15.7.1.2. Intraluminal or Endocavitary Methods
15.7.1.3. Continuous Hyperthermic Peritoneal Perfusion (CHPP)
15.7.1.4. Deep Tissue & Regional Perfusion
15.7.2. Whole-body
15.8. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by Application
15.9. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by Application
15.9.1. Breast Cancer
15.9.2. Liver Cancer
15.9.3. Soft Tissue Sarcoma
15.9.4. Head & Neck Tumors
15.9.5. Prostate Cancer
15.9.6. Others
15.10. Middle East & Africa Hyperthermia Cancer Treatment Market Value Share and Attractiveness Analysis, by End-user
15.11. Middle East & Africa Hyperthermia Cancer Treatment Market Forecast, by End-user
15.11.1. Hospitals & Specialty Clinics
15.11.2. Ambulatory Surgical Centers
15.11.3. Others
16. Competition Landscape
16.1. Competition Matrix
16.2. Company Profiles
16.2.1. Pyrexar Medical
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Strategic Overview
16.2.2. Celsius42 GmbH
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Strategic Overview
16.2.3. Hydrosun GmbH
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Strategic Overview
16.2.4. Oncotherm Kft
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Strategic Overview
16.2.5. Andromedic S.r.l.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Strategic Overview
16.2.6. Yamamoto Vinita Co., Ltd.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Strategic Overview
16.2.7. Chongqing Haifu Medical Technology Co., Ltd
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Strategic Overview
16.2.8. innoMedicus Ltd.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Strategic Overview
16.2.9. Gamida
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Strategic Overview
16.2.10. RanD.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Strategic Overview
Table 02: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 03: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 04: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 05: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 06: Global Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 07: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 08: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 09: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 10: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030
Table 11: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 12: North America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 13: Europe Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 14: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 15: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 16: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 17: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 18: Europe Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 19: Asia Pacific Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 20: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 21: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 22: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional, 2018–2030
Table 23: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 24: Asia Pacific Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 25: Latin America Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 27: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 28: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 29: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 30: Latin America Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 31: Middle East & Africa Hyperthermia Cancer Treatment Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 32: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Device Type, 2018–2030
Table 33: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Treatment Method, 2018–2030
Table 34: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Locoregional Method, 2018–2030
Table 35: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 36: Middle East & Africa Hyperthermia Cancer Treatment Market Value (US$ Mn) Forecast, by End-user, 2018–2030